Reproductive experiences of women who cryopreserved oocytes for non-medical reasons
K Hammarberg, M Kirkman, N Pritchard… - Human …, 2017 - academic.oup.com
STUDY QUESTION What are the reproductive experiences of women who cryopreserve
oocytes for non-medical reasons? SUMMARY ANSWER One in three women had been …
oocytes for non-medical reasons? SUMMARY ANSWER One in three women had been …
Nanoparticles in pregnancy: the next frontier in reproductive therapeutics
N Pritchard, T Kaitu'u-Lino, L Harris… - Human reproduction …, 2021 - academic.oup.com
BACKGROUND Nanotechnology involves the engineering of structures on a molecular level.
Nanomedicine and nano-delivery systems have been designed to deliver therapeutic …
Nanomedicine and nano-delivery systems have been designed to deliver therapeutic …
Characteristics and circumstances of women in Australia who cryopreserved their oocytes for non-medical indications
N Pritchard, M Kirkman, K Hammarberg… - … of reproductive and …, 2017 - Taylor & Francis
Objective: This study aimed to explore the characteristics and circumstances of women who
cryopreserved their oocytes for non-medical indications and their reasons for …
cryopreserved their oocytes for non-medical indications and their reasons for …
Reductions in stillbirths and preterm birth in COVID-19–vaccinated women: a multicenter cohort study of vaccination uptake and perinatal outcomes
Background COVID-19 infection in pregnancy is associated with a higher risk of progression
to severe disease, but vaccine uptake by pregnant women is hindered by persistent safety …
to severe disease, but vaccine uptake by pregnant women is hindered by persistent safety …
[HTML][HTML] Circulating SPINT1 is a biomarker of pregnancies with poor placental function and fetal growth restriction
…, I Bittar, AN Sferruzzi-Perri, N Pritchard… - Nature …, 2020 - nature.com
Placental insufficiency can cause fetal growth restriction and stillbirth. There are no reliable
screening tests for placental insufficiency, especially near-term gestation when the risk of …
screening tests for placental insufficiency, especially near-term gestation when the risk of …
EGFR (epidermal growth factor receptor) signaling and the mitochondria regulate sFlt-1 (soluble FMS-like tyrosine kinase-1) secretion
Preeclampsia is a hypertensive disorder of pregnancy characterized by maternal endothelial
dysfunction and end-organ damage. The antiangiogenic factor, sFlt-1 (soluble FMS-like …
dysfunction and end-organ damage. The antiangiogenic factor, sFlt-1 (soluble FMS-like …
[HTML][HTML] ELABELA/APELA levels are not decreased in the maternal circulation or placenta among women with preeclampsia
N Pritchard, J Tu'uhevaha, S Gong, J Dopierala… - The American journal of …, 2018 - Elsevier
The genetic deletion of apelin receptor early endogenous ligand (Elabela; official name
APELA) produces a preeclampsia-like phenotype in mice. However, evidence linking ELABELA …
APELA) produces a preeclampsia-like phenotype in mice. However, evidence linking ELABELA …
[HTML][HTML] Identification of the optimal growth charts for use in a preterm population: An Australian state-wide retrospective cohort study
NL Pritchard, RJ Hiscock, E Lockie, M Permezel… - PLoS …, 2019 - journals.plos.org
Background Preterm infants are a group at high risk of having experienced placental insufficiency.
It is unclear which growth charts perform best in identifying infants at increased risk of …
It is unclear which growth charts perform best in identifying infants at increased risk of …
[HTML][HTML] Circulating mRNAs are differentially expressed in pregnancies with severe placental insufficiency and at high risk of stillbirth
…, K Chindera, S Karegodar, R Hiscock, N Pritchard… - BMC medicine, 2020 - Springer
Background Fetuses affected by placental insufficiency do not receive adequate nutrients
and oxygenation, become growth restricted and acidemic, and can demise. Preterm fetal …
and oxygenation, become growth restricted and acidemic, and can demise. Preterm fetal …
Circulating growth differentiation factor 15 is increased preceding preeclampsia diagnosis: implications as a disease biomarker
…, TV Nguyen, R Hiscock, N Pritchard… - Journal of the …, 2021 - Am Heart Assoc
Background We investigated the biomarker potential of growth differentiation factor 15 (GDF‐15),
a stress response protein highly expressed in placenta, to predict preeclampsia. …
a stress response protein highly expressed in placenta, to predict preeclampsia. …